会員ページ

所属、メールアドレス等に変更があった方はログイン後、変更届画面から、登録内容を変更してください

出版

臨床放射線腫瘍学

最新知見に基づいた放射線治療の実践 オンラインアクセス権付

臨床放射線腫瘍学 さてこの度、南江堂より日本放射線腫瘍学会と日本放射線腫瘍学研究機構編集の共同出版である『臨床放射線腫瘍学』が発刊されました。
放射線腫瘍医,専門医をめざす研修医,医学物理士,その他がん治療に携わる医師(腫瘍内科,腫瘍外科)を対象とした放射線腫瘍学の教科書で、各疾患のケーススタディーも多くを掲載され、より臨床的に即した実践的な内容の教科書です。

詳細は株式会社南江堂ホームページをご覧ください
http://www.nankodo.co.jp/g/g9784524263226/



業績

Tatsuya Ohno, Masaru Wakatsuki, Takafumi Toita, Yuko Kaneyasu, Ken Yoshida, Shingo Kato, Noriko Ii, Sunao Tokumaru, Hitoshi Ikushima, Takashi Uno, Shin-ei Noda, Tomoko Kazumoto and Yoko Harima, the Working Group of the Gynecological Tumor Committee of the Japanese Radiation Oncology Study Group (JROSG): Recommendations for high-risk clinical target volume definition with computed tomography for three-dimensional image-guided brachytherapy in cervical cancer patients. Journal of Radiation Research, 2016, pp. 1-10 doi: 10.1093

Nishimura Y, Jingu K, Itasaka S, Negoro Y, Murakami Y, Karasawa K, Kawaguchi G, Isohashi F, Kobayashi M, Itoh Y, Ariga T.Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG). Int J Clin Oncol. 2016 Feb;21(1):88-94.

Hidefumi Aoyama, MD, PhD; Masao Tago, MD, PhD; Hiroki Shirato, MD, PhD; et al. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial. JAMA Oncol. Published online May 14, 2015. doi:10.1001/jamaoncol.2015.1145
*Research Selected for ASCO's Clinical Cancer Advances 2016

Sahgal A, Aoyama H, Kocher M, Neupane B, Collette S, Tago M, Shaw P, Beyene J, Chang EL. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):710-7. doi: 10.1016/j.ijrobp.2014.10.024.

Maebayashi T, Ishikawa H, Yorozu A, Yoshida D, Katoh H, Nemoto K, Ishihara S, Takemoto S, Ishibashi N, Tokumaru S, Akimoto T; Working Subgroup of Urological Cancers in Japanese Patterns of practice in the radiation therapy for bladder cancer: survey of the Japanese Radiation Oncology Study Group (JROSG). Radiation Oncology Study Group. Jpn J Clin Oncol. 2014 44(11):1109-15

Aoki M, Mizowaki T, Akimoto T, Nakamura K, Ejima Y, Jingu K, Tamai Y, Nakajima N, Takemoto S, Kokubo M, Katoh H.Adjuvant radiotherapy after prostatectomy for prostate cancer in Japan: a multi-institutional survey study of the JROSG. J Radiat Res. 2014 55(3):533-40

悪性リンパ腫に対する放射線治療の新しい動き ISRTを中心に小口 正彦, 長谷川 正俊, 石橋 直也, 磯部 公一, 今井 美智子, 江島 泰生, 糟谷 健夫, 片山 絵美子, 笹井 啓資, 副島 俊典, 早渕 尚文 臨床血液 (0485-1439)55巻10号 Page1903-1911(2014.10)

Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Hatano K, Yoshimura M, Yamada K, Tokumaru S, Sekiguchi K, Kobayashi M, Soejima T, Isohashi F, Nemoto K, Nishimura Y, the Japanese Radiation Oncology Study Group (JROSG). Factors influencing survival outcome for radiotherapy for biliary tract cancer: A multicenter retrospective study. Radiother Oncol 2014;110:546-52

Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Kanesaka N, Tamamoto T, Kosugi T, Hatano K, Kobayashi M, Ito Y, Takayama M, Takemoto M, Karasawa K, Nagakura H, Imai M, Kosaka Y, Yamazaki H, Isohashi F, Nemoto K, Nishimura Y, and the Japanese Radiation Oncology Study Group (JROSG). Impact of intraluminal brachytherapy on survival outcome for radiation therapy for unresectable biliary tract cancer: A propensity-score matched-pair analysis. Int J Radiat Oncol Biol Phys 2014;89:822-9

Naoto Shikama, Kenji Sekiguchi, Naoki Nakamura, Hiroshi Sekine, Yuko Nakayama, Kazufumi Imanaka, Takeshi Akiba, Masahiko Aoki, Yoshiomi Hatayama, Etsuko Ogo, Yoshikazu Kagami,Miho Kawashima, and Kumiko Karasawa. Preliminary Results from a Multi-center Prospective Study (JROSG 05-5) on Postoperative Radiotherapy for Patients with High-risk Ductal Carcinoma in situ with Involved Margins or Margin Widths 1 mm or less than. Columbia International Publishing American Journal of Breast Cancer Research (2014) Vol. 1 No. 1 pp. 1-8

Nakamura N, Shikama N, Wada H, Harada H, Nozaki M, Nagakura H, Tago M, Oguchi M, Uchida N.Variability in the point to which single direct field irradiation is prescribed for spinal bone metastases: a survey of practice patterns in Japan. J Radiat Res. 2013 1;54(6):1065-8

Isohashi F, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T, Kanesaka N, Tamamoto T, Asakura H, Kosugi T, Uno T, Ito Y, Karasawa K, Takayama M, Manabe Y, Yamazaki H, Takemoto M, Yoshioka Y, Nemoto K, Nishimura Y; Japanese Radiation Oncology study Group (JROSG).Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey. Radiat Oncol. 2013 Apr 1;8:76

Fumiaki Isohashi, Kazuhiko Ogawa, Hirobumi Oikawa, Hiroshi Onishi, Nobue Uchida, Toshiya Maebayashi,Naoto Kanesaka, Tetsuro Tamamoto, Hirofumi Asakura, Takashi Kosugi, Takashi Uno, Yoshinori Ito,Katsuyuki Karasawa, Makoto Takayama, Yoshihiko Manabe, Hideya Yamazaki, Mitsuhiro Takemoto,Yasuo Yoshioka, Kenji Nemoto, Yasumasa Nishimura on behalf of the Japanese Radiation Oncology study Group (JROSG) Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey. Radiation Oncology 8: 76-85,2013.

Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (‹4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys. 2012; 82: e49-56.

Tokumaru S, Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Yamauchi C, Suzuki O, Sakurai H, Teshima T, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N, Kudo S.Insufficiency Fractures After Pelvic Radiation Therapy for Uterine Cervical Cancer: An Analysis of Subjects in a Prospective Multi-institutional Trial, and Cooperative Study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG). Int J Radiat Oncol Biol Phys 84(2): e195-200, 2012.

Nakamura N, Shikama N, Wada H, Harada H, Nozaki M, Nagakura H, Tago M, Oguchi M, Uchida N; Japanese Radiation Oncology Study Group Working Subgroup of Palliative Radiotherapy. Pattern of practice in palliative radiotherapy for painful bone metastases: a survey in Japan. Int J Radiat Oncol Biol Phys 83(1): e117-120, 2012.

Nishimura Y, Hiraoka M, Koike R, Nakamatsu K, Itasaka S, Kawamura M, Negoro Y, Araki N, Ishikawa H, Fujii T, Mitsuhashi N.Long-term follow-up of a randomized phase II study of cisplatin/5-Fu concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021).Jpn J Clin Oncol 42(9): 807-812, 2012.

Ogawa K, Ito Y, Hirokawa N, Shibuya K, Kokubo M, Ogo E, Shibuya H,Saito T, Onishi H, Karasawa K, Nemoto K, Nishimura Y, and the JROSG Working Subgroup of Gastrointestinal Cancers. Concurrent radiotherapy and Gemcitabine for unresectable pancreatic adenocarcinoma: Impact of adjuvant chemotherapy on survival. Int J Radiat Oncol Biol Phys 83(2): 559-565, 2012.

Toita T, Kato S, Niibe Y, Ohno T, Kazumoto T, Kodaira T, Kataoka M, Shikama N, Kenjo M, Tokumaru S, Yamauchi C, Suzuki O, Sakurai H, Numasaki H, Teshima T, Oguchi M, Kagami Y, Nakano T, Hiraoka M, Mitsuhashi N.Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (‹4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2). Int J Radiat Oncol Biol Phys 82(1): e49-56, 2012.

Nishimura Y, Koike R, Ogawa K, Sasamoto R, Murakami Y, Itoh Y, Negoro Y, Itasaka S, Sakayauchi T, Tamamoto T. Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: the Japanese Radiation Oncology Study Group (JROSG) Survey. Int J Clin Oncol 17(1): 48-54, 2011.

Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K, Nishimura Y: Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys 80(1): 111-118, 2011.

三橋 紀夫:特定非営利法人日本放射線腫瘍学機構 (Radiation Oncology Study Group: JROSG) の活動~多施設共同臨床試験を中心に~.映像情報メディカル42(12): 1042-1046, 2010.

Ogawa K, Shibuya H, Uchida N, Onishi H, Okuno Y, Myojin M, Kobayashi M, Ogawa Y, Kanesaka N, Shibuya K, Tokumaru S, Sasamoto R, Karasawa K, Nemoto K, Nishimura Y: Postoperative external beam radiotherapy for resected pancreatic adenocarcinoma: impact of chemotherapy on local control and survival. Anticancer Res 30(7): 2959-2967, 2010.

Ogawa K, Ito Y, Karasawa K, Ogawa Y, Onishi H, Kazumoto T, Shibuya K, Shibuya H, Okuno Y, Nishino S, Ogo E, Uchida N, Karasawa K, Nemoto K, Nishimura Y: Pattern of radiotherapy practice for pancreatic cancer in Japan: results of the Japanese Radiation Oncology Study Group (JROSG) survey. Int J Radiat Oncol Biol Phys 77(3): 740-750, 2010.

Ogawa K, Karasawa K, Ito Y, Ogawa Y, Jingu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K, Nishimura Y: Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys 77(3): 743-742, 2010.

Sakayauchi T, Nemoto K, Ishioka C, Onishi H, Yamamoto M, Kazumoto T, Makino M, Yonekura R, Itami J, Sasaki S, Suzuki G, Hayabuchi N, Tamamura H, Onimaru R, Tamamoto T, Yamada S. Comparison of cisplatin and 5-fluorouracil chemotherapy protocols combined with concurrent radiotherapy for esophageal cancer. Jpn J Radiol 27(3):131-137, 2009.

Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kodaira T, Kazumoto T, Kataoka M, Shikama N, Kenjo M, Teshima T, Kagami Y. Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: the individual case review. Jpn J Clin Oncol 39(12): 813-819, 2009.

Nishimura Y, Mitsumori M, Hiraoka M, Koike R, Nakamatsu K, Kawamura M, Negoro Y, Fujiwara K, Sakurai H, Mitsuhashi M. A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021) Radiotherapy and Oncolog. 92(2): 260-265, 2009.

Sakata K, Sakurai H, Suzuki Y, Katoh S, Ohno T, Toita T, Kataoka M, Tanaka E, Kaneyasu Y, Uno T, Harima Y, Nakano T; Japan Radiation Oncology Study Group.: Results of concomtant chemoradiotherapy for cervical cancer using high dose rate intracavitary brachetherapy: study of JROSG (Japan Radiation Oncology Study Group). Acta Oncol 47(3): 434-441, 2008.

Nakamura K, Mizowaki T, Imada H, Karasawa K, Uno T, Onishi H, Nihei K, Sasaki S, Ogura M, Akimoto T.: External-beam radiotherapy for localized or locally advanced prostate cancer in Japan: a multi-institutional outcome analysis. Jpn J Clin Oncol 38(3): 200-204, 2008.

Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Matsuno Y, Oguchi M.; A Multicenter Phase II Study of Local Radiation Therapy for Stage IEA Mucosa-Associated Lymphoid Tissue Lymphomas: A Preliminary Report from the Japan Radiation Oncology Group (Jarog). Int J Radiat Oncol Biol Phys 69(4): 1181-1186, 2007.

Isobe K, Kagami Y, Higuchi K, Kodaira T, Hasegawa M, Shikama N, Nakazawa M, Fukuda I, Nihei K, Ito K, Teshima T, Oguchi M.; Initial Experience with the Quality Assurance Program of Radiation Therapy on behalf of Japan Radiation Oncology Group (JAROG). Jpn J Clin Oncol 37(2): 135-139, 2007.

Aoyama H, Tago M, Kato N, Toyoda T, Kenjyo M, Hirota S, Shioura H, Inomata T, Kunieda E, Hayakawa K, Nakagawa K, Kobashi G, Shirato H. Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68(5): 1388-1395, 2007.

Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M; Oya O, Hirota S; Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21): 2483-2491, 2006.

Karasawa K, Mitsumori M, Yamauchi C, Gomi K, Kataoka M, Uematsu T, Kodaira T, Yamakawa M, Karasawa K, Watanabe T, Tsujino K, Hiraoka M.: Treatment outcome of breast-conserving therapy in patients with positive or close resection margins: Japanese multi-institutional survey for radiation dose effect. Breast Cancer 12(2): 91-98, 2005.

論文

癌の臨床 Vol.56 No.7 2010.7 特集
JROSG(Japanese Radiation Oncology Study Group)の現状

■脳・中枢神経腫瘍委員会p489-492
芝本 雄太 前林 勝也

■頭頚部腫瘍委員会p493-498
中村 達也 古平 毅 茂松 直之 寺原 敦朗 山崎 拓也 不破信和 兼平 千裕 

■消化器腫瘍委員会p499-504
西村 恭昌 小川 和彦

■肺・縦隔腫瘍委員会p505-510
永田 靖 木村 智樹

■乳腺腫瘍委員会p511-516
唐澤 久美子 鹿間 直人

■婦人科腫瘍委員会p517-524
中野 隆史 戸板 孝文 徳丸 直郎 大野 達也 坂田 耕一 加藤 真吾 宇野 隆 清原 浩樹 新部 譲 田中 英一 楮本 智子 兼安 祐子 西村 哲夫 五味 弘道 高橋 健夫 播磨 洋子

■泌尿器腫瘍委員会p525-530
秋元 哲夫 中村 和正 溝脇 尚志 萬 篤憲 加藤 弘之 小塚 拓洋 前林 俊也 青木 学 幡野 貴志 石川 仁 平塚 純一

■悪性リンパ腫・血液腫瘍委員会p531-536
小口 正彦 長谷川 正俊 磯部 公一 笹井 啓資 今井 美智子 江島 泰生 齋藤 淳一

■小児腫瘍委員会p 537-544
正木 英一

■緩和医療委員会p545-550
鹿間 直人